FDA Import Refusal AEK-3780870-3/41/1 — RANBAXY PHARMACEUTICALS CANADA
The FDA refused shipment AEK-3780870-3/41/1 from RANBAXY PHARMACEUTICALS CANADA (Canada) on Sep 13, 2017. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Sep 13, 2017
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61JCH08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75